Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Neutron Science (12)
- Biological Systems (1)
- Biology and Environment (16)
- Clean Energy (6)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Isotopes (6)
- Materials (7)
- Materials for Computing (2)
- National Security (2)
- Nuclear Science and Technology (2)
- Supercomputing (17)
News Type
News Topics
- (-) Biomedical (12)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (1)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (6)
- Biology (6)
- Biotechnology (1)
- Chemical Sciences (3)
- Clean Water (2)
- Climate Change (1)
- Composites (1)
- Computer Science (13)
- Coronavirus (8)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (6)
- Environment (8)
- Fossil Energy (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (3)
- Materials (14)
- Materials Science (23)
- Mathematics (1)
- Microscopy (3)
- Nanotechnology (10)
- National Security (2)
- Neutron Science (101)
- Nuclear Energy (3)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (2)
- Space Exploration (3)
- Summit (6)
- Sustainable Energy (2)
- Transportation (5)
Media Contacts
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.